OCTOBER 2020: FALL UPDATE

OCTOBER 2020: FALL UPDATE

As a result of the successful financing round of CHF 10 million in April 2020, the InnoMedica team was able to reach important milestones in the main projects Talidox and Talineuren in the last months and make progress in the…

April 2020: Capital increase with public offering

April 2020: Capital increase with public offering

Please find below the relevant investor documents (including subscription form). Information on InnoMedica and the projects TaliCoVax-19 (vaccination), Talidox (oncology) and Talineuren (neurology) can be found in the business documentation. Investor Documentation Download Business Documentation 2020   Download last year’s…

March 2020: InnoMedica launches project for corona vaccination

March 2020: InnoMedica launches project for corona vaccination

The corona pandemic is a major challenge for everyone. In this context, InnoMedica can contribute its expertise to the development of an urgently needed vaccine. InnoMedica has good contacts with the Institute for Virology and Immunology IVI in Mittelhäusern, BE…